HomeNNCSF • OTCMKTS
add
Nanosonics Ltd.
Previous close
$3.06
Year range
$1.69 - $3.30
Market cap
1.36B AUD
Avg Volume
221.00
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 52.52M | 16.22% |
Operating expense | 35.66M | 11.70% |
Net income | 5.46M | 60.44% |
Net profit margin | 10.39 | 37.98% |
Earnings per share | — | — |
EBITDA | 6.51M | 77.85% |
Effective tax rate | 4.14% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 161.64M | 24.77% |
Total assets | 272.48M | 14.81% |
Total liabilities | 62.57M | 13.48% |
Total equity | 209.91M | — |
Shares outstanding | 303.63M | — |
Price to book | 4.43 | — |
Return on assets | 4.86% | — |
Return on capital | 6.09% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 5.46M | 60.44% |
Cash from operations | 11.40M | 65.77% |
Cash from investing | -1.38M | -118.65% |
Cash from financing | -924.50K | -19.60% |
Net change in cash | 8.58M | 52.67% |
Free cash flow | 5.17M | 47.14% |
About
Nanosonics is a ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe, employing more than 300 people.
The company’s Trophon is the product used to reduce the spread of Healthcare Acquired Infections. Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Wikipedia
Founded
2001
Headquarters
Website
Employees
470
